autologous tumor cell vaccine

Known as: AC vaccine, ATCV, Autologous Cell Vaccine 
A therapeutic agent produced by isolating tumor cells from an individual and processing these tumor cells into a vaccine formulation in vitro; the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1979-2015
024619792015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
We report a single center phase II trial of sequential vaccination followed with vaccine plus interleukin-2 (IL-2). Vaccination… (More)
Is this relevant?
2005
2005
BACKGROUND Head and neck squamous cell carcinomas (HNSCCs) are aggressive tumors with poor 5-year survival rates, thus demanding… (More)
Is this relevant?
2004
2004
For active specific immunotherapy of cancer patients, we designed the autologous virus–modified tumor cell vaccine ATV-NDV. The… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 5
Is this relevant?
2004
2004
Prognosis of patients with advanced head and neck squamous cell carcinomas (HNSCC) is still poor. Therefore, we analyzed whether… (More)
  • table 1
  • figure 2
  • figure 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PURPOSE Prognosis of patients with glioblastoma is poor. Therefore, in glioblastoma patients, we analyzed whether antitumor… (More)
Is this relevant?
2003
2003
AIM To treat patients with stage I-IV malignant tumors of digestive tract using autologous tumor cell vaccine and NDV (Newcastle… (More)
Is this relevant?
2002
2002
PURPOSE A reason that the immune system may fail to reject tumors is that T cells encounter tumor antigen derived peptides on the… (More)
Is this relevant?
2002
2002
The EBV/lipoplex is a nonviral gene delivery system composed of a cationic lipid and Epstein-Barr virus (EBV)-based plasmid… (More)
Is this relevant?
2000
2000
PURPOSE A randomized phase III clinical trial of adjuvant active specific immunotherapy (ASI) with an autologous tumor cell… (More)
Is this relevant?
1990
1990
Active specific immunotherapy was performed in a phase I study in 20 colorectal cancer patients after surgical resection of the… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?